Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-06-29

Clinical Trial Update: The eSVS® Mesh Post-Marketing Trial [NA]

View source ↗

Summary

The post-marketing trial of the eSVS Mesh has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • eSVS Mesh

Snippet

Sponsor: Kips Bay Medical, Inc. | Conditions: Coronary Artery Disease, Myocardial Ischemia | NA | Status: TERMINATED